立即博

贝博足球中文博彩平台最新网址德州扑克平台新葡京线上赌场澳门网络博彩游戏

Have any questions? 706-721-6582 or [email protected]

AU Study Recruitment

Study Name	Principal Investigator
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications	Kota, Vamsi
A Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants with Chronic Myeloid Leukemia	Cortes, Jorge
A RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF CEMACABTAGENE ANSEGEDLEUCEL IN PARTICIPANTS WITH MINIMAL RESIDUAL DISEASE AFTER RESPONSE TO FIRST LINE THERAPY FOR LARGE B-CELL LYMPHOMA (ALPHA3)	Bryan, Locke
BP1001-201-AML: A Phase IIa, Open-label, Clinical Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of BP1001 (a Liposomal Grb2 Antisense Oligonucleotide) in Combination with Venetoclax plus Decitabine in Patients with Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Induction Therapy	Kota, Vamsi
Evaluation of cholecalciferol (VitD3) supplementation in patients with multiple myeloma (MM) before transplantation and in combination with lenalidomide maintenance	Keruakous, Amany
KO-MEN-008 Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia	Cortes, Jorge
Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries	Kota, Vamsi
Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries	Kota, Vamsi
Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction: A Randomized, Controlled Trial (SCHOLAR-2)	Guha, Avirup

RESEARCH. INNOVATION. DISCOVERY.

Augusta University

Research

AU Health

Stay Informed

韦德注册信誉新葡京网上赌场足球博彩app 在线博彩排名正规博彩平台正规赌博软件